Nextremity Solutions, Inc. Receives FDA 510(k) Clearance for Lesser Tarsometatarsal (TMT) Joint Arthrodesis System

By |2020-01-06T08:00:11+00:00January 6th, 2020|News|

Warsaw, Indiana, January 6, 2020 — Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., today announced it has [...]